TNF-
-induced cell death in ethanol-exposed cells depends on p38 MAPK signaling but is independent of Bid and caspase-8
John G. Pastorino,
Nataly Shulga, and
Jan B. Hoek
Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson
University, Philadelphia, Pennsylvania 19107
Submitted 15 October 2002
; accepted in final form 14 May 2003
 |
ABSTRACT
|
---|
Alcoholic liver disease is associated with an increase in the number of
necrotic and apoptotic liver parenchymal cells. Part of this injury is
mediated by TNF-
. Ethanol exposure sensitizes cells to the cytotoxic
effects of TNF-
. This may be due, in part, to the increased propensity
of the mitochondria in ethanol-exposed cells to induction of mitochondrial
permeability transition (MPT) by various agents, including the proapoptotic
protein Bax. This idea is supported by the observation that increased cell
death induced by TNF-
in ethanol-exposed cells was dependent on
development of the MPT. In the present study, we elucidate the pathways
through which ethanol exposure enhances TNF-
induction of the MPT and
the resulting cytotoxicity. Specifically, ethanol-exposed cells display
caspase-8- and Bid-independent cell killing during TNF-
treatment.
Moreover, the ethanol-enhanced pathway is dependent on p38 MAPK signaling,
which brings about caspase-3 activation, mitochondrial depolarization,
accumulation of cytochrome c in the cytosol, and the translocation of
Bax to the mitochondria. Additionally, ethanol-exposed cells display a
blunting of TNF-
-induced Akt activation and Bcl-2 antagonist of cell
death phosphorylation that may account, in part, for the increased sensitivity
of the mitochondria to Bax-mediated damage.
alcoholic hepatitis; Bax; caspase-3; mitochondria; apoptosis
ALCOHOLIC LIVER DISEASE (ALD) in the United States is estimated
to affect >2 million people
(12). ALD consists of the
three major pathological entities: alcoholic steatosis, alcoholic hepatitis,
and cirrhosis. These lesions usually occur sequentially, although they may
coexist in any combination and occur independently. Proinflammatory cytokines
such as TNF-
and IL-6 have been linked to many of the associated damage
and repair processes seen in ALD
(21,
35). Indeed many of the
effects exerted by TNF-
are clinical manifestations of alcoholic
hepatitis such as fever, neutrophilia, anorexia, and muscle wasting.
TNF-
is very pleiotropic in its effects on hepatocytes, causing mitosis
or cytotoxicity, depending on the metabolic state of the cell and the presence
of other cytokines and chemokines
(13). TNF-
seems to
play a critical role in the development of ALD. Depletion of
TNF-
-producing Kupffer cells by gadolinium chloride prevented the
development of hepatocyte injury in a rat intragastric feeding model
(1). In addition, neutralizing
antibodies to TNF-
also prevented the onset of liver damage
(23). There is an increase in
spontaneous and LPS-mediated TNF-
bioactivity in the supernatants of
monocytes from ALD patients
(36). Patients with severe ALD
and mortality had higher plasma TNF-
concentrations than those who
survived, with a correlation between plasma TNF-
levels and serum
bilirubin and creatinine values
(26). Thus there is strong
evidence that TNF-
contributes to liver injury in ALD.
TNF-
and its receptor (TNFR) belong to the large TNF-
-related
ligand and TNF-
/nerve growth factor receptor families. The TNF-
ligand binds to TNFR in a trimeric state, inducing receptor trimerization and
activation. There are 75- and 55-kDa TNFRs (TNFR75 and TNFR55, respectively).
Only TNFR55 possesses a cytoplasmic binding motif termed the death domain that
mediates caspase activation (5,
6). Caspases are capable of
activating each other and themselves, which has lent support to the existence
of a caspase cascade (48). The
pathway leading from the binding of TNF-
to TNFR55 and caspase
activation involves the recruitment of cytosolic proteins that contain a death
domain. The TNFR55-associated death domain protein (TRADD) binds to TNFR55.
TRADD then induces the binding of Fas-associated protein with death domain
(FADD) that recruits caspase-8 (FLICE). The complex of proteins thus formed is
referred to as the death-inducing signaling complex (DISC)
(45,
53). Oligomerization of
caspase-8 in the DISC has been demonstrated to induce self processing and
activation of the enzyme, which is then capable of activating downstream group
II caspases, such as -3 and -7. The formation of the DISC and the activation
of caspase-8 is a critical decision point in the ultimate fate of the cell.
This is demonstrated by the existence of FLICE-inhibitory protein (FLIP)
(25,
55). FLIP acts as a decoy
protein of caspase-8, binding to FADD, thus becoming incorporated into the
DISC. However, FLIP is unable to become an active caspase and initiate the
caspase cascade because of a substitution of a tyrosine for an active site
cysteine.
The level of caspase-8 activation in the DISC has led to the categorization
of cells into two general classes, types I and II
(46,
47). In type I cells,
caspase-8 is activated to a level ample to directly cleave and activate
downstream caspases such as caspase-3. By contrast, in type II cells, the
level of caspase-8 activation appears to be inadequate to set off the caspase
cascade alone. However, the caspase-8 that is activated is sufficient enough
to cleave Bid. Bid is a proapoptotic protein that belongs to the Bcl-2 family
(28,
31). The cleavage product of
Bid, truncated Bid (tBid), translocates to the mitochondria and induces the
release of proapoptotic factors from the mitochondrial intermembrane space,
such as apoptosis-inducing factor and cytochrome c. In turn, these
agents can cause the activation of caspase-3, which can cause further
mitochondrial damage, thus initiating a self-amplifying loop
(49).
Besides caspase-8, TNF-
also activates the stress kinase p38.
TNF-
is known to activate p38 MAPK either through transforming growth
factor-
-activated kinase or apoptosis-stimulating kinase (ASK-1)
(22,
27,
44). In some instances the
activation of p38 MAPK may be important in mediating mitochondrial
dysfunction. Activation of p38 MAPK has been demonstrated to promote
cytochrome c release and Bax translocation to the mitochondria with
the subsequent release of deleterious intermembrane space proteins
(16). In the present study, we
demonstrate that ethanol exposure is capable of altering the pathway by which
TNF-
can cause mitochondrial damage. In particular, we demonstrate that
TNF-
induces an elevated and prolonged activation of p38 MAPK in
ethanol-exposed cells. Moreover, this p38 MAPK activity is responsible for
mediating a translocation of Bax to the mitochondria and subsequent induction
of mitochondrial dysfunction. Importantly, all of these effects are
independent and distinct from the pathway initiated by caspase-8 activation.
These findings suggest a mechanism through which ethanol exposure can
sensitize cells to TNF-
-induced mitochondrial dysfunction and the
resulting cytotoxicity.
 |
EXPERIMENTAL PROCEDURES
|
---|
Cell culture and treatments. Hepatoma G2E47 (HepG2E47) cells that
express cytochrome P-4502E1 (CYP2E1) (kindly provided by Dr. Arthur
I. Cederbaum) were maintained in 25-cm2 polystyrene culture flasks
with 5 ml MEM containing 100 U/ml penicillin, 0.1 mg/ml streptomycin, 0.4
mg/ml G418, 1 mM pyruvate, and 10% heat-inactivated FBS (complete MEM)
incubated under an atmosphere of 95% air-5% CO2 at 37°C. Cells
were subcultured 1:5 once a week. The cells were treated with 25 mM ethanol
for 48 h before treatment with TNF-
. The culture medium was replaced
every 24 h with fresh medium containing ethanol. To prevent evaporation of
ethanol, the flasks or plates were placed in a plastic dessicator in the
incubator containing a mixture of water and ethanol. After 24 h of ethanol
exposure, the cells (control or ethanol treated) were trypsinized, counted in
a hemocytometer, and plated at 1.0 x 105 cells into
1.88-cm2 wells of a 24-well plate for cell viability and membrane
potential measurements or into 6-well, 9.3-cm2 plates at 1.0
x 106 cells for determination of caspase-3 or -8 activity.
The cells were allowed to attach and spread for 24 h. When present, ethanol
was added back to the cells during this time (total time of ethanol exposure,
48 h). On the day of the experiment, the cells were washed and placed in MEM
without serum and in the absence of ethanol. Cells were pretreated for 30 min
with one of the following reagents. Ile-Glu(Ome)-Thr-Asp(Ome)
fluoromethylketone (IETD-FMK) and SB-203580 were dissolved in DMSO and added
to the wells in a 0.2% volume for a final concentration of 1 and 5 µM,
respectively. Control cultures received a comparable volume of DMSO.
Cycloheximide (CHX) was dissolved in water and added to the cell cultures at a
final concentration of 1 µM also 30 min before TNF-
addition. Thirty
minutes after treatment with the above reagents, TNF-
was added.
TNF-
was dissolved in PBS and added to the wells in a 0.2% volume to
give a final concentration of 10 ng/ml (220 U/ml).
Preparation of hepatocytes. Male Sprague-Dawley rats (140-160 g)
were obtained from Charles River Laboratories (Raleigh, NC). Nutritionally
adequate liquid diets were formulated according to the method of Leiber and
DeCarli (30). The
ethanol-containing diet consisted of 18% total calories as protein, 35% as
fat, 11% as carbohydrate, and 36% as ethanol. In the control diet, ethanol was
replaced isocalorically with maltose-dextrin. Isolated hepatocytes were
prepared by collagenase perfusion
(20). Yields of 2-4 x
108 cells per liver with 90-95% viability as assessed by Trypan
blue exclusion were routinely obtained. Hepatocytes were either plated in 24-
or 6-well plates at 1.0 x 105 or 1.0 x 106
cells per well, respectively. The cells were treated with TNF-
alone or
in combination with IETD-FMK or SB-203580 as indicated in Cell culture and
treatments for the HepG2E47 cells.
Measurements of cell viability. Cell viability was determined by
Trypan blue exclusion and the ability of cells to reduce
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS). For Trypan blue exclusion, 10 µl of a 0.5% solution of Trypan blue
was added to the wells. Both viable and nonviable cells were counted for each
data point in a total of eight microscopic fields. For the MTS assay, the
reaction was started by the addition of MTS and phenazine methosulfate (PMS).
The absorbance change obtained on reduction of MTS by viable cells was read 90
min later with a plate reader at 490 nm. One-hundred percent cell death was
determined by the addition of Triton X-100 to a final concentration of 0.5%,
30 min before MTS and PMS addition. The MTS assay and Trypan blue exclusion
gave identical results.
Measurement of mitochondrial energization. Mitochondrial
energization was determined as the retention of the dye
3,3'-dihexyloxacabocyanine
[DiOC6(3)]
(Molecular Probes Eugene, OR). Cells were loaded with 40 nM of
DiOC6(3) during the
last 30 min of treatment. The cells were then washed twice in PBS. The level
of retained DiOC6(3)
was measured on a Cytofluor-2 fluorescence plate reader at 488-nm excitation
and 500-nm emission.
Detection of caspase-3 and caspase-8 activity. The assay is based
on the ability of the active enzymes to cleave the chromophore pNA from the
enzyme substrates DEVD-pNA (caspase-3) or IETD-pNA (caspase-8). Cell extracts
were prepared and diluted 1:1 with 2x reaction buffer (10 mM Tris, pH
7.4, 1 mM dithiothreitol, 2 mM EDTA, 0.1% CHAPS, 1 mM PMSF, 10 µg/ml
pepstatin, 10 µg/ml leupeptin). DEVD-pNA or IETD-pNA were added to a final
concentration of 50 µM, and the reaction incubated for1hat37°C. Samples
were then transferred to a 96-well plate, and absorbance measurements were
made in a 96-well plate reader at 405 nm.
Isolation of cytosolic and mitochondrial fractions. Cells were
plated in 25-cm2 flasks at 5.0 x 106 cells per
flask. After treatments, the cells were harvested by trypsinization followed
by centrifugation at 600 g for 10 min at 4°C. The cell pellets
were washed once in PBS and then resuspended in 3 volumes of isolation buffer
(in mM: 20 HEPES, pH 7.4, 10 KCl, 1.5 MgCl2, 1 sodium-EDTA, 1
dithiothreitol, 10 PMSF, and 1.0 µg/ml leupeptin, 1.0 µg/ml aprotinin in
250 mM sucrose). After being chilled on ice for 3 min, the cells were
disrupted by 40 strokes of a glass homogenizer. The homogenate was centrifuged
twice at 2,500 g at 4°C to remove unbroken cells and nuclei. The
mitochondria were then pelleted by centifugation at 12,000 g at
4°C for 30 min. The supernatant was removed and filtered through 0.2 µm
and then 0.1-µm Ultrafree MC filters (Millipore) followed by centrifugation
at 100,000 g at 4°C to yield cytosolic protein. Cytosolic
fractions (25 µg protein) were separated on 12% SDS-PAGE gels and
electroblotted onto nitrocellulose membranes. Cytochrome c was
detected by a monoclonal antibody (Pharmingen, San Diego, CA) at a dilution of
1:5,000. Secondary goat anti-mouse horseradish peroxidase-labeled antibody
(Santa Cruz Biotechnology, Santa Cruz CA) diluted at 1:10,000 was detected by
enhanced chemiluminescence.
Western blot analysis. After various treatments, equal numbers of
cells were harvested by trypsinization and centrifugation at 500 g
for 5 min and washed once with PBS. Cell pellets were then lysed in SDS sample
buffer. Samples were separated on 12% SDS-PAGE and electroblotted onto
nitro-cellulose membranes. Phospho-BAD-136 and BAD were detected by rabbit
polyclonal antibody at a dilution of 1:500 (Cell Signaling Technology,
Beverly, MA). Bax was detected with an antibody that binds to the
NH2 terminus N-20 (Santa Cruz Biotechnology). Bid was detected with
a rabbit polyclonal antibody capable of detecting tBid (Biosource, Camarillo,
CA). In each case, the relevant protein was visualized by staining with the
appropriate secondary horseradish peroxidase-labeled antibody (1:10,000) and
was detected by enhanced chemiluminescence.
ELISA of Akt and p38 MAPK activation. Cells were collected in PBS
by centrifugation. The cells were then lysed in cell extraction buffer (in mM:
10 Tris, pH 7.4, 100 NaCl, 1 EDTA, 1 EGTA, 1 NaF, 20
Na4P2O7,2Na3VO4, 1
PMSF, and protease inhibitor cocktail plus 1% Triton X-100, 10% glycerol, 0.1%
SDS, 0.5% deoxycholate). Standards, samples, or controls were added to
microtiter wells coated with the appropriate antibody (anti-p38 MAPK or
anti-Akt). The wells were covered and incubated for2hat room temperature. The
wells were then decanted and thoroughly washed four times. One hundred
microliters of an antibody, either anti-p38 MAPK (pTpy180/182), anti-p38 MAPK,
anti-Akt (pS473), or anti-Akt was added to the wells and incubated for1hat
room temperature. The solution was decanted, and the wells were washed four
times. Afterward, 100 µl of horseradish peroxidase-conjugated anti-rabbit
IgG was added to each well. The wells were incubated for an additional 30 min.
The wells were decanted and washed four times. Then 100 µl stabilized
chromogen was added to each well and incubated for 30 min in the dark; 100
µl stop solution was then added to each well. The absorbance of each well
was then read at 450 nm on a Synergy HTS microplate reader.
 |
RESULTS
|
---|
Ethanol exposure promotes caspase-8-independent cell killing by
TNF-
. HepG2E47, which express the ethanol-metabolizing enzyme
CYP2E1, were pretreated with 25 mM ethanol for 48 h. The cells were then
treated with 10 ng/ml TNF-
(230 IU/ml)
(Fig. 1, A and
B). Alternatively, primary hepatocytes were isolated from
control or ethanol-fed animals. The cells were plated overnight and then
treated as indicated (Fig. 1, C
and D). As demonstrated in
Fig. 1, A and
C, TNF-
treatment of ethanol-exposed HepG2E47
cells or primary hepatocytes obtained from ethanol-fed animals resulted in a
loss of cellular viability of >60 to 70% at 6 h. By contrast, hepatocytes
isolated from control-fed animals and HepG2E47 cells not exposed to ethanol
displayed only a 10% loss of cell viability after a 6-h exposure to
TNF-
(Fig. 1, A and
C). Inhibition of translation and transcription
sensitizes many cells to TNF-
cytotoxicity. This is thought to be due
to an inhibition of the protective response of the cell to TNF-
and
depletion of proteins such as inhibitors of apoptosis and FLIP that bind to
and inhibit caspases. As demonstrated in
Fig. 1, A and
C, HepG2E47 cells or hepatocytes from control-fed animals
treated with TNF-
in the presence of the translational inhibitor CHX
exhibited a loss of cell viability that was similar in time course and extent
to that of ethanol-exposed cells treated with TNF-
or hepatocytes
isolated from ethanol-fed animals (Fig. 1,
A and C). However, despite their similarity in
the time course and extent of cell death induced by TNF-
, the response
of the cells to inhibition of caspase-8 differed markedly between the two
treatment conditions. HepG2E47 cells treated with TNF-
and ethanol or
TNF-
and CHX were pretreated for 30 min with the caspase-8 inhibitor,
IETD-FMK. As shown in Fig.
1B, IETD-FMK prevented the cell killing brought about by
TNF-
and CHX but was without effect on the loss of cell viability
caused by TNF-
and ethanol. Similar results were seen in hepatocytes
where the caspase-8 inhibitor prevented the cell killing induced by
TNF-
and CHX (Fig.
1D) in control-fed animals but not that induced by
TNF-
alone in hepatocytes isolated from ethanol-fed animals
(Fig. 1D). Because of
these results, we examined the activity of caspase-8 in the two treatment
protocols. As shown in Fig.
2A, caspase-8 is quickly activated in HepG2E47 cells
treated with TNF-
and CHX, with activity reaching a maximum of
eightfold above control levels at 1.5 h. By contrast, HepG2E47 cells treated
with TNF-
and ethanol displayed a lower level of caspase-8 activation
compared with that of cells treated with TNF-
plus CHX, with the
maximal level attained being only half of that seen in TNF-
- and
CHX-treated cells.
Caspase-8 can activate caspase-3 either directly as in type I cells or
through a mitochondrial pathway as in so-called type II cells. As shown in
Fig. 2A, treatment of
HepG2E47 cells with TNF-
and ethanol or TNF-
and CHX both lead
to an increase in caspase-3 activity that was sixfold above control levels
between 3 and 4 h after TNF-
treatment. However, as demonstrated in
Fig. 2B, pretreatment
of the cells with the caspase-8 inhibitor prevented caspase-3 activation in
TNF-
- and CHX-treated cells but did not prevent the increase in
caspase-3 activity brought about by TNF-
and ethanol, despite the
ability of the inhibitor to eliminate caspase-8 activity under both treatment
conditions. These results clearly demonstrate that caspase-3 activation
triggered by TNF-
in CHX-treated cells is dependent on upstream
caspase-8 activation but is independent of caspase-8 activity when brought
about by TNF-
in ethanol-exposed cells. Importantly, similar results
with regards to TNF-
-induced caspase activation were obtained in
primary hepatocytes isolated from ethanol-fed rats. Caspase-8 and -3
activities reached four- and eightfold above control levels at 2 and 4 h,
respectively (Fig.
2C). TNF-
did not bring about activation of
caspase-8 or -3 in hepatocytes isolated from control-fed animals, consistent
with the lack of cell killing under these conditions (results not shown).
Identical to HepG2E47 cells exposed to ethanol, the caspase-8 inhibitor
prevented the caspase-8 activation induced by TNF-
in hepatocytes
isolated from ethanol-fed animals (Fig.
2D) but did not diminish the activity of caspase-3
(Fig. 2D).
The robust caspase-8 activity seen in TNF-
- and CHX-treated cells is
probably due to a depletion of endogenous caspase inhibitors such as FLIP by
translational inhibition. As mentioned above, FLIP is an inactive decoy of
caspase-8 that has been shown to inhibit caspase-8 activation and prevent cell
killing. HepG2E47 cells were transfected with an expression construct for FLIP
24 h before treatment of ethanol-exposed cells with TNF-
or of
non-ethanol-exposed cells with TNF-
and CHX. As shown in
Table 1, FLIP overexpression
suppressed the cell killing brought about by TNF-
and CHX but not that
caused by TNF-
and ethanol. These results demonstrate that even an
endogenous inhibitor of caspase-8 such as FLIP does not inhibit the cell
killing induced by TNF-
and ethanol.
Activation of p38 MAPK is both necessary and sufficient for
TNF-
- and ethanol-induced cytotoxicity. The p38 MAPK
cascade is activated by a variety of cellular stresses including TNF-
(Fig. 3). Therefore, the
effects of ethanol exposure on the time course of p38 MAPK activation induced
by TNF-
were determined by ELISA. In non-ethanol-exposed HepG2E47 cells
or hepatocytes, by 15 min, p38 MAPK phosphorylation was twofold above basal
values (0 time point) in cells treated with TNF-
alone or TNF-
and CHX and declined back down to basal levels by 45 min. HepG2E47 cells
exposed to ethanol and hepatocytes isolated from ethanol-fed animals exhibited
an increase of p38 MAPK activation that was similar initially to that of
non-ethanol-exposed cells. Treatment of both HepG2E47 cells exposed to ethanol
or hepatocytes isolated from ethanol-fed animals with TNF-
produced an
increase of phosphorylated p38 MAPK of twofold above basal levels at 15 min
that then declined back down to basal levels by 45 min. However, in contrast
to non-ethanol-exposed cells, there was a robust elevation of p38 MAPK
activation starting at 60 min and reaching a maximum of three- to fourfold
above basal levels at 2 h and remaining elevated even after 4 h. Importantly,
it should be noted that treatment with TNF-
under either condition did
not result in an increase in the absolute level of p38 MAPK protein as
determined by ELISA (results not shown).
We then wanted to determine whether p38 MAPK activation played a role in
TNF-
and ethanol-induced cell killing. As before, HepG2E47 cells were
exposed for 48 h to ethanol and then treated with TNF-
. However, in
some cases the cells were pretreated for 30 min with the p38 MAPK inhibitor,
SB-203580, before the addition of TNF-
. As demonstrated in
Fig. 4A, TNF-
and ethanol caused a 72% loss of cell viability over 6 h. By contrast, cells
pretreated with SB-203580 were still 95% viable after 6 h of TNF-
treatment of ethanol-exposed cells. Importantly, as shown in
Table 2, other inhibitors of
p38 MAPK that are chemically distinct from SB-203580 also protected against
TNF-
- and ethanol-induced cell killing. In addition, SB-202474, a
compound with a similar chemical structure to SB-203580 but inactive against
p38 MAPK, did not inhibit TNF-
- and ethanol-induced cell killing.
Surprisingly, inhibition of p38 MAPK activity did not prevent the cell killing
brought about by TNF-
and CHX treatment, with a >70% loss of cell
viability seen after 6 h of treatment, in the presence of the p38 MAPK
inhibitor SB-203580 (Fig.
4A), levels of cell killing similar to that seen with
TNF-
and CHX alone. Similar results were found in hepatocytes isolated
from control-fed vs. ethanol-fed animals, where TNF-
-induced cell
killing in hepatocytes isolated from ethanol-fed animals was prevented by the
inhibitor of p38 MAPK (Fig.
4C) but had no effect on the loss of cell viability in
hepatocytes isolated from control-fed animals caused by the combination of
TNF-
and CHX (Fig.
4C).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 4. TNF- induced cytotoxicity and caspase-3 activation are dependent on
p38 MAPK signaling in ethanol-exposed cells. HepG2E47 cells were exposed to 25
mM ethanol for 48 h or left untreated. Cells were then washed and pretreated
for 30 min with 5 µM of the p38 MAPK inhibitor SB-203580 or left untreated.
The cells were then treated with 10 ng/ml of TNF- alone in
ethanol-exposed cells or in combination with CHX in nai
ïve cells. Cell viability (A) and caspases-3 and -8
activities (B) were determined as described in
EXPERIMENTAL PROCEDURES. Similarly, hepatocytes isolated from
control-fed or ethanol-fed animals were pretreated for 30 min with 5 µM of
the p38 MAPK inhibitor SB-203580 or left untreated. Cell viability
(C) and caspases-3 and -8 activities (D) were determined as
for HepG2E47 cells. Data are means ± SD from 3 independent
experiments.
|
|
View this table:
[in this window]
[in a new window]
|
Table 2. Effect of chemically distinct inhibitors of p38 MAPK on
TNF- -induced cell killing in HepG2E47 cells exposed to ethanol
|
|
We then examined the effect of inhibiting p38 MAPK on caspase-8 and -3
activities. Pretreatment of the cells with SB-203580 had no effect on the time
of onset or level of activation of caspase-8 induced by TNF-
in either
ethanol-exposed HepG2E47 cells or in hepatocytes isolated from ethanol-fed
animals (Fig. 4, B and
D). However, inhibition of p38 MAPK markedly prevented
caspase-3 activation in both ethanol-exposed HepG2E47 cells and hepatocytes
isolated from ethanol-fed animals (Fig. 4,
B and D). Importantly, the p38 MAPK inhibitor
did not prevent the caspase-3 activation induced by TNF-
in combination
with CHX in either HepG2E47 cells or hepatocytes (results not shown),
consistent with the inability of p38 inhibition to prevent cell killing under
these conditions.
Inhibition of p38 MAPK prevents mitochondrial dysfunction in
TNF-
- and ethanol-exposed cells. Mitochondrial injury has
been demonstrated to be a pivotal event in both apoptotic and necrotic cell
death. As shown in Fig. 5, A and
C, HepG2E47 cells exposed to ethanol or hepatocytes
obtained from ethanol-fed animals treated with TNF-
displayed a loss of
mitochondrial membrane potential over 3 h. A similar loss of mitochondrial
energization was seen in HepG2E47 cells not exposed to ethanol or in
hepatocytes isolated from control-fed animals treated with TNF-
and CHX
(Fig. 5, B and
D). Importantly, inhibition of p38 MAPK activity
prevented the onset of mitochondrial depolarization brought about by
TNF-
in HepG2E47 cells exposed to ethanol and in hepatocytes isolated
from ethanol-fed animals (Fig. 5,
A and C) but not in those treated with
TNF-
and CHX (Fig. 5, B and
C). Conversely, the caspase-8 inhibitor IETD-FMK
prevented mitochondrial denergization in TNF-
- and CHX-treated cells
(Fig. 5, B and
D) but not in TNF-
- and ethanol-exposed cells
(Fig. 5, A and
B). Mitochondrial dysfunction during cell injury is
associated with the release of injurious mitochondrial intermembrane space
proteins such as cytochrome c. As demonstrated in
Fig. 6, A and
C, lane 2, there was an accumulation of
cytochrome c in the cytosol of TNF-
- and CHX-treated HepG2E47
cells (A) or hepatocytes obtained from control-fed animals
(C) that was maximal at 2 h, a time point coinciding with the onset
of caspase-3 activation. Accumulation of cytochrome c in the cytosol
of TNF-
-and CHX-treated cells was prevented by caspase-8 inhibition but
not by p38 MAPK inhibition (Fig. 6,
A and C, lanes 3 and 4,
respectively). Treatment with TNF-
of ethanol-exposed HepG2E47 cells
(B) or hepatocytes isolated from ethanol-fed animals (D)
exhibited an accumulation of cytochrome c in the cytosol similar to
that of TNF-
- and CHX-treated cells, with maximal accumulation seen at
2 h post-TNF-
treatment (Fig. 6,
B and D, lane 2). However, the exact
opposite results were obtained in TNF-
- and ethanol-exposed cells
compared with TNF-
- and CHX-treated cells regarding the effects of
caspase-8 and p38 MAPK inhibition. Whereas caspase-8 inhibition prevented
cytochrome c release in TNF-
- and CHX-treated cells, it had no
effect on the release of cytochrome c induced by TNF-
in
ethanol-exposed HepG2E47 cells or in hepatocytes isolated from ethanol-fed
animals (Fig. 6, B and
D, lane 3). By contrast, p38 MAPK inhibition had
no effect on cytochrome c accumulation in the cytosol of
TNF-
-and CHX-treated cells (Fig. 6,
A and C, lane 4) but completely
prevented that induced by TNF-
in ethanol-exposed cells
(Fig. 6, B and
D, lane 4).

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 6. Differential effects of inhibiting p38 MAPK signaling vs. caspase-8
activity on TNF- induced cytochrome c redistribution in
ethanol- or CHX-treated cells. HepG2E47 cells were either exposed to 25 mM
ethanol for 48 h or left untreated (A and B). Alternatively,
hepatocytes were isolated from control or ethanol-fed animals (C and
D). Cells were then pretreated with 5 µM of SB-203580 or 1 µM
of IETD-FMK for 30 min. Cells were then treated with 10 ng/ml TNF-
either alone in the ethanol-exposed cells or in combination with CHX in
nai
ïve cells. At 2 h posttreatment, cells were harvested and cytosolic
fractions were then prepared as described in EXPERIMENTAL
PROCEDURES. Samples were normalized for protein content and run out on
12% SDS-PAGE and then electroblotted onto nitrocellulose membranes. Cytochrome
c was detected by using an anti-cytochrome c monoclonal
antibody and a secondary horseradish peroxidase-labeled antibody. Blots were
visualized by using enhanced chemiluminescence. Results are typical of 3
independent experiments.
|
|
The role of reactive oxygen species in p38 MAPK activation.
HepG2E47 cells exposed to ethanol or hepatocytes isolated from ethanol-fed
animals were either treated with TNF-
alone or pretreated for1hwiththe
antioxidant ebselen and then treated with TNF-
. As demonstrated in
Fig. 7, pretreatment of either
ethanol-exposed HepG2E47 (A) or hepatocytes isolated from ethanol-fed
animals (B) with ebselen prevented the initial spike in p38 MAPK
activation induced by TNF-
, suggesting that it may be mediated by the
generation of reactive oxygen species (ROS). Importantly, this initial
activation of p38 MAPK was also seen in non-ethanol-exposed cells treated with
TNF-
(Fig. 3). However,
ebselen did not prevent the secondary and much greater and more sustained
increase of p38 MAPK activation characteristic of ethanol-exposed cells
treated with TNF-
(Fig. 7,
A and B). Such results suggest that the
secondary increase of p38 MAPK induced by TNF-
in ethanol-exposed cells
may be brought about by mechanisms other than ROS.
Ethanol exposure promotes a p38-mediated translocation of Bax to the
mitochondria during TNF-
treatment. A number of
proapoptotic proteins of the Bcl-2 family have been demonstrated to mediate
mitochondrial injury. Bid is a BH3-domain protein that is cleaved and
truncated by caspase-8 to a more active form, tBid. As demonstrated in
Fig. 8A, lane
1, mitochondria isolated from HepG2E47 cells treated with TNF-
and
CHX show an accumulation of tBid that reached a maximum at 1 h. Importantly,
the accumulation of mitochondrial tBid was prevented by caspase-8 inhibition,
thus suggesting that caspase-8 activation is a prerequisite for Bid
translocation to the mitochondria in TNF-
- and CHX-treated cells
(Fig. 8A, lane
2). By contrast, cells exposed to ethanol and subsequently treated with
TNF-
displayed no mitochondrial accumulation of tBid
(Fig. 8A, lane
4). This observation may be due to the low level of caspase-8 activity
detected under these treatment conditions. Interestingly, p38 MAPK inhibition
had no effect on tBid accumulation in TNF-
- and CHX-treated cells, in
agreement with the inability of the p38 MAPK inhibitor to prevent caspase-8
activation under these treatment conditions
(Fig. 8A, lane
3). Bax is another member of the Bcl-2 family that is proapoptotic and
induces mitochondrial injury. Moreover, the translocation of Bax to the
mitochondria has been shown to be induced by p38 MAPK under some
circumstances. Because TNF-
treatment of ethanol-exposed cells
generated no accumulation of tBid in the mitochondria, we wanted to determine
whether Bax could account for the mitochondrial dysfunction observed. As shown
in Fig. 8B, Bax
accumulates markedly in the mitochondria of TNF-
- and ethanol-exposed
cells, reaching a maximum at 2 h post-TNF-
treatment. This accumulation
of Bax at the mitochondria was dependent on p38 MAPK activation as
demonstrated by the ability of SB-203580 to inhibit it at 2 h
(Fig. 8B, lane
5). By contrast, inhibition of caspase-8 had no effect on mitochondrial
Bax accumulation in ethanol-exposed cells treated with TNF-
(Fig. 8B, lane
6). The cell killing brought about by TNF-
and ethanol was
dependent on Bax. We suppressed the expression of Bax in the HepG2E47 cells by
using an antisense construct. As demonstrated in
Fig. 9A, a 5-day
treatment with the Bax antisense eliminated Bax expression. As shown in
Fig. 9B, the cells
treated with the Bax antisense oligonucleotide exhibited resistance to the
cell killing brought about by TNF-
in ethanol-exposed cells.
Importantly, treatment with the sense oligonucleotide had no effect on Bax
expression or TNF-
- and ethanol-induced cytotoxicity.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 8. TNF- induces a p38 MAPK-dependent translocation of Bax to the
mitochondria in ethanol-exposed cells. HepG2E47 cells were either exposed to
25 mM ethanol for 48 h or left untreated. Cells were then pretreated with 5
µM of SB-203580 or 1 µM of IETD-FMK. Cells were subsequently treated
with 10 ng/ml TNF- either alone in the ethanol-exposed cells or in
combination with CHX in nai
ïve cells. At the indicated posttreatment times, the cells were
harvested and mitochondrial fractions were then prepared as described in
EXPERIMENTAL PROCEDURES. Samples were normalized for protein
content and run out on 15% SDS-PAGE and electroblotted onto nitrocellulose
membranes. Bax was detected by using an anti-Bax monoclonal antibody and an
anti-mouse horseradish peroxidase-labeled secondary antibody. Bid was detected
with a rabbit polyclonal antibody capable of detecting the truncated form.
Blots were visualized by using enhanced chemiluminescence. The results are
typical of 3 independent experiments. tBid, truncated Bid.
|
|
Inhibition of TNF-
-induced Akt activation and BAD
phosphorylation in ethanol-exposed cells. BAD is a proapoptotic member of
the Bcl-2 family that does not induce mitochondrial dysfunction in and of
itself. However, BAD does increase the susceptibility of the mitochondria to
proteins like Bax, by binding to and inhibiting the ability of antiapoptotic
proteins such as Bcl-2 and Bcl-XL to prevent Bax-induced damage. We
have previously demonstrated
(41) that TNF-
brings
about the phosphorylation of BAD and its resultant sequestration in the
cytosol. Therefore, we determined whether the effects of ethanol on
TNF-
-induced cell killing could be explained, at least in part, by
ethanol having an effect on TNF-
-induced BAD phosphorylation. As
demonstrated in Fig.
10A, treatment of HepG2E47 cells with TNF-
alone
resulted in an increase in the levels of phosphorylated BAD over a 120-min
time course. In contrast, cells exposed to ethanol for 48 h exhibited a
significant blunting of TNF-
-induced BAD phosphorylation. Notably, the
total level of BAD was unchanged by TNF-
or ethanol treatment in either
condition. A similar inhibition of TNF-
-induced BAD phosphorylation was
seen in hepatocytes isolated from ethanol-fed rats
(Fig. 10B). BAD is
phosphorylated on serines 112 and 136 by AKT/PKB. It is possible that ethanol
treatment may inhibit BAD phosphorylation and thereby potentiate cell killing
by affecting the phosphatidylinositol 3-kinase (PI3-kinase)/Akt pathway.
Similar to p38 MAPK, we measured the activation of Akt by ELISA. As shown in
Fig. 11, both HepG2E47 cells
exposed to ethanol (A) and hepatocytes isolated from ethanol-fed
animals (B) exhibited an increase of basal Akt activation over that
of non-ethanol-exposed cells (0 time point). Treatment of ethanol-naiïve
HepG2E47 cells or hepatocytes isolated from control-fed animals with
TNF-
or TNF-
and CHX induced a marked increase of Akt activation
that reached a maximum at 60 min. By contrast, TNF-
-induced Akt
activation was markedly blunted in HepG2E47 cells exposed to ethanol and in
hepatocytes isolated from ethanol-fed animals. To further demonstrate the
importance of ethanol exposure in hindering TNF-
-induced Akt
activation, HepG2E47 cells were transiently transfected with a cDNA encoding a
constitutively active form of Akt (myr-Akt). As demonstrated in
Table 3, HepG2E47 cells
expressing constitutively active myr-Akt were rescued from the cell killing
induced by TNF-
and ethanol exposure.
View this table:
[in this window]
[in a new window]
|
Table 3. Expression of constitutively active Akt protects against
TNF- -induced cytotoxicity in ethanol-exposed cells
|
|
 |
DISCUSSION
|
---|
In the present studies, we show that ethanol exposure promotes a
TNF-
-induced cytotoxicity that is mediated by sustained p38 MAPK
activation and is independent of caspase-8 and Bid activation. Inhibition of
p38 MAPK signaling prevented the translocation of Bax to the mitochondria in
TNF-
- and ethanol-treated cells, with a resultant prevention of cell
death. Moreover, the effects of ethanol are further compounded by the ability
of ethanol exposure to blunt TNF-
-induced Akt activation and
phosphorylation of BAD. Expression of a constitutively active form of Akt/PKB
ameliorated the loss of cell viability induced by TNF-
and ethanol.
The effects of ethanol on mitochondrial function are mutifactorial.
Mitochondria isolated from ethanol-fed rats exhibit an increase in
acetaldehyde protein adducts and ROS production and a decrease in GSH levels,
mitochondrial DNA, and complex I and III activities, among other alterations
(3,
7,
14). HepG2E47 cells, which
express the ethanol-inducible and -metabolizing enzyme CYP2E1 display similar
alterations in mitochondrial function and a propensity for induction of the
mitochondrial permeability transition (MPT)
(39,
56,
57). Such alterations leave
the mitochondria vulnerable to secondary insults. Indeed, we have demonstrated
that mitochondria isolated from ethanol-fed rats are more susceptible to
induction of the MPT induced by a wide variety of agents, including Bax
(40). This increased
sensitivity of the mitochondria is reflected in the ability of TNF-
to
induce cytotoxicity in HepGE47 cells exposed to ethanol and in primary
hepatocytes isolated from ethanol-fed rats in the absence of transcriptional
or translational inhibitors
(39). Similar results have
been reported in cultured astrocytes, in which exposure of the cells to 5 mM
ethanol increased their sensitivity to TNF-
(11).
However, despite the finding that ethanol exposure sensitized cells to
TNF-
-induced cell death, the signaling pathways through which this was
mediated remained unclear. As mentioned, the assembly of the DISC at the TNFR
results in the activation of caspase-8. In type I cells, caspase-8 activation
is sufficient to activate downstream effector caspases such as caspase-3.
However, in type II cells such as HepG2E47, the amount of caspase-8 activated
is inadequate to cleave and initiate caspase-3 activity to a level sufficient
to induce cell death. In type II cells it has been shown that a mitochondrial
pathway augments the ability of caspase-8 to bring about cell killing.
Caspase-8 cleaves the BH3-protein Bid at an internal aspartate site to yield a
truncated 15-kDa protein (tBid) that translocates to the mitochondria
(29). tBid has been shown to
release cytochrome c in isolated mitochondria and intact cells
(31,
34). However, tBid is also
capable of interacting with Bax. In nonapoptotic cells, Bax is located in the
cytosol and in loose association with mitochondria
(17). On an apoptotic
stimulus, the COOH-terminal domain of Bax is unmasked, which promotes
translocation and the insertion of Bax into the mitochondrial membrane
(17,
37,
38,
43,
51). tBid is capable of
interacting with Bax to induce this conformational transformation and
subsequent induction of mitochondrial injury
(10). Indeed, it has been
demonstrated that a tBid-dependent conformational change of Bax is suppressed
by E1B-19K, an adenovirus gene product capable of binding Bax and inhibiting
apoptosis in TNF-
- and CHX-treated HeLa cells
(42). However, E1B-19K did not
prevent caspase-8 activation or cleavage of Bid. Such results suggest that,
although caspase-8 and tBid are necessary for Bax to assume an active
conformation, caspase-8 and tBid are not sufficient under all circumstances by
themselves to induce cell death. Indeed, the TNF-
family member
TNF-
-related apoptosis-inducing ligand induced robust caspase-8
activation and formation of tBid in Bax-negative cells, despite its inability
to induce cell death in these same cells
(9).
Such results point to the fact that Bax in and of itself can bring about
mitochondrial damage and cell death. However, to accomplish this, Bax must
assume an active conformation. As mentioned, the binding of tBid can bring
this about. However, Bax can also undergo translocation to the mitochondria by
a p38 MAPK-dependent mechanism. Indeed, it has been demonstrated that p38 MAPK
kinase activity plays a critical role in nitric oxide-mediated cell death in
neurons by stimulating Bax translocation to the mitochondria
(16). Similarly, T-cell
receptor stimulation of thymocytes resulted in a p38 MAPK-mediated
translocation of Bax to the mitochondria with a resultant disruption in
mitochondrial membrane potential, release of cytochrome c, and
caspase-3 activation (58). All
of these effects were independent of caspase-8 activity and tBid. Inhibition
of p38 MAPK activity also protects against the cell killing induced by singlet
oxygen, ultraviolet B radiation, cadmium, doxorubicin, and ischemia
(2,
15,
24,
32,
33,
60) However, at present, the
mechanism by which p38 MAPK brings about Bax translocation is unknown. Direct
phosphorylation of Bax by p38 MAPK has not been demonstrated. Active p38 MAPK
may phosphorylate an inhibitory binding partner of Bax such as Bcl-2. Indeed,
nerve growth factor withdrawal in B-lymphocytes induces a p38 MAPK-dependent
phosphorylation of Bcl-2 that was required for apoptosis
(50).
The mode by which ethanol exposure increases the duration and intensity of
TNF-
-induced p38 MAPK activation is a matter under current
investigation. Ethanol is known to have an inhibitory effect on the activity
of some phosphatases. Ethanol may inhibit the MAPK phosphatase activity (MKP-1
and -2) that dephosphorylates and inactivates p38 MAPK. Overexpression of
MKP-1 protected rat mesangial cells from TNF-
-induced cell killing
(19). Alternatively, ethanol
may enhance TNF-
-induced apoptosis-activated kinase-1 (ASK-1)
activation, a MAPKKK. ASK-1 binds to thioredoxin
(44). Thioredoxin is a direct
inhibitor of ASK-1 signaling. Thioredoxin binding and inhibition of ASK-1 is
redox sensitive. TNF-
or hydrogen peroxide treatment of cells resulted
in a dissociation of thioredoxin from ASK-1, with the resultant activation of
ASK-1. As mentioned, ethanol exposure promotes an oxidative stress in cells;
such a state of oxidative stress may potentiate TNF-
-induced activation
of ASK-1 and the downstream p38 MAPK. However, it must be pointed out that
ethanol exposure also potentiates TNF-
-induced cytotoxicity in HepG2
cells not expressing CYP2E1, albeit over a longer time course of TNF-
treatment (39). In addition,
the antioxidant ebselen, although preventing an initial TNF-
-induced
spike of p38 MAPK stimulation, did not prevent the more sustained and greater
increase of p38 MAPK activation seen in ethanol-exposed cells. These results
suggest that ethanol may have effects on the ability of TNF-
to elicit
the p38 MAPK pathway independent of those mediated by oxidative stress.
It has been demonstrated that Akt downregulates p38 MAPK activity
(4,
18). Therefore, the
possibility exists that ethanol exposure may potentiate p38 MAPK signaling by
inhibiting the PI3-kinase/Akt pathway. Indeed, in the present study, we have
demonstrated that ethanol exposure inhibits TNF-
-induced Akt activation
and BAD phosphorylation, a phosphorylation that most likely is mediated by
Akt.
By whatever mechanism that ethanol exposure potentiates p38 MAPK
activation, ethanol's deleterious effects on mitochondria in
TNF-
-treated cells are most likely compounded by its ability to inhibit
BAD phosphorylation induced by TNF-
. BAD is phosphorylated by multiple
kinases including PKA, Raf-1, and Akt. We have demonstrated that TNF-
induces phosphorylation of BAD on serine 136 and that this is mediated by Akt
(41). Indeed, inhibition of
the PI3-kinase/Akt pathway potentiates TNF-
-induced cytotoxicity.
Others (59) have also
demonstrated that ethanol exposure inhibits the PI3-kinase signaling pathway
induced by receptor activation. As demonstrated in Figs.
10 and
11, both HepG2E47 cells
exposed to ethanol and hepatocytes isolated from ethanol-fed animals displayed
an inhibition of TNF-
-induced Akt activation and BAD phosphorylation on
serine 136. Moreover, the toxicity of TNF-
in ethanol-exposed cells was
ameliorated by expression of constitutively active Akt. Phosphorylation of BAD
promotes its binding to the cytosolic protein, 14-3-3
(54). When unphosphorylated,
BAD is localized to the mitochondria. However, unlike Bax, BAD is not directly
damaging to the mitochondria
(8,
28). Rather, its association
with Bcl-2 and/or Bcl-XL is thought to increase the susceptibility
of the mitochondria to damage by proteins such as Bax. By binding to
Bcl-2/Bcl-XL, BAD neutralizes their ability to bind and inhibit
Bax. Additionally, it has recently been demonstrated that the PI3-kinase/Akt
pathway can also suppress the translocation of Bax to the mitochondria
(52). This result suggests
that ethanol exposure may have a three-tier effect on the ability of Bax to
promote mitochondrial dysfunction, by increasing p38 MAPK's and decreasing
PI3-kinase/Akt's ability to promote and inhibit, respectively, Bax
translocation to the mitochondria and by enhancing Bax's ability to cause
mitochondrial injury by inhibiting BAD phosphorylation.
In summary, ethanol exposure potentiates p38 MAPK activation induced by
TNF-
. In turn, the increased p38 MAPK activity seen in an
ethanol-exposed cell treated with TNF-
is necessary and sufficient to
mediate the translocation of Bax to the mitochondria in which it induces
mitochondrial damage resulting in the release of deleterious intermembrane
space proteins such as cytochrome c. Moreover, the translocation of
Bax occurs through a pathway that is independent and distinct from that
mediated by caspase-8 activation and Bid cleavage
(Fig. 12). Because p38 MAPK
activity has been demonstrated to be necessary and sufficient for cell death
in other contexts, it will be important to determine the mechanism by which
ethanol potentiates p38 MAPK activity and, in turn, how this brings about Bax
activation. Additionally, the mechanism by which ethanol exposure prevents
TNF-
-stimulated Akt activation and phosphorylation of BAD and the
effects that this has on Bax's ability to induce mitochondrial dysfunction
will need to be clarified. The elucidation of ethanol's effects on these
pathways will help decipher how it potentiates TNF-
-induced
cytotoxicity and perhaps provide a better understanding of the pathogenesis of
hepatocyte injury in ALD.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 12. Ethanol promotes Bax-induced mitochondrial dysfunction by enhancing p38
activation and inhibiting the phosphatidylinositol 3-kinase (PI3K)/Akt
pathway. TNFR, TNF receptor; ASK, apoptosis-activated kinase; ROS, reactive
oxygen species.
|
|
 |
DISCLOSURES
|
---|
This study was supported by National Institute on Alcohol Abuse and
Alcoholism Grants KO1-AA-00330-1 and 1-R01-AA-12897-01A2.
 |
FOOTNOTES
|
---|
Address for reprint requests and other correspondence: J. G. Pastorino, Dept.
of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Rm. 269,
Jefferson Alumni Hall, Philadelphia, PA 19107 (E-mail:
John.Pastorino{at}jefferson.edu).
The costs of publication of this article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
 |
REFERENCES
|
---|
- Adachi Y,
Bradford BU, Gao W, Bojes HK, and Thurman RG. Inactivation of Kupffer
cells prevents early alcohol-induced liver injury.
Hepatology 20:
453-460, 1994.[ISI][Medline]
- Assefa Z,
Vantieghem A, Garmyn M, Declercq W, Vandenabeele P, Vandenheede JR, Bouillon
R, Merlevede W, and Agostinis P. p38 mitogen-activated protein kinase
regulates a novel, caspase-independent pathway for the mitochondrial
cytochrome c release in ultraviolet B radiation-induced apoptosis.
J Biol Chem 275:
21416-21421, 2000.[Abstract/Free Full Text]
- Bailey SM and
Cunningham CC. Contribution of mitochondria to oxidative stress associated
with alcoholic liver disease. Free Radic Biol Med
32: 11-16,
2002.[ISI][Medline]
- Berra E,
Diaz-Meco MT, and Moscat J. The activation of p38 and apoptosis by the
inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway.
J Biol Chem 273: 10792-10797, 1998. [Corrigendum. J Biol
Chem 273: June 26, 1998, p.
16630.][Free Full Text]
- Boldin MP, Mett
IL, Varfolomeev EE, Chumakov I, Shemer-Avni Y, Camonis JH, and Wallach D.
Self-association of the "death domains" of the p55 tumor necrosis
factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1
effects. J Biol Chem 270:
387-391, 1995.[Abstract/Free Full Text]
- Boldin MP,
Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, and Wallach D. A novel
protein that interacts with the death domain of Fas/APO1 contains a sequence
motif related to the death domain. J Biol Chem
270: 7795-7798,
1995.[Abstract/Free Full Text]
- Cahill A, Wang
X, and Hoek JB. Increased oxidative damage to mitochondrial DNA following
chronic ethanol consumption. Biochem Biophys Res
Commun 235:
286-290, 1997.[ISI][Medline]
- Chao DT and
Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev
Immunol 16:
395-419, 1998.[ISI][Medline]
- Deng Y, Lin Y,
and Wu X. TRAIL-induced apoptosis requires Bax-dependent mitochondrial
release of Smac/DIABLO. Genes Dev
16: 33-45,
2002.[Abstract/Free Full Text]
- Desagher S,
Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K,
Antonsson B, and Martinou JC. Bid-induced conformational change of Bax is
responsible for mitochondrial cytochrome c release during apoptosis.
J Cell Biol 144:
891-901, 1999.[Abstract/Free Full Text]
- DeVito WJ,
Stone S, and Shamgochian M. Ethanol increases the neurotoxic effect of
tumor necrosis factor-
in cultured rat astrocytes. Alcohol
Clin Exp Res 24:
82-92, 2000.[ISI][Medline]
- Diehl AM.
Alcoholic liver disease: natural history. Liver Transpl
Surg 3: 206-211,
1997.[Medline]
- Diehl AM.
Cytokines and the molecular mechanisms of alcoholic liver disease.
Alcohol Clin Exp Res 23:
1419-1424, 1999.[ISI][Medline]
- Fernandez-Checa JC, Garcia-Ruiz C, Colell A, Morales A, Mari M,
Miranda M, and Ardite E. Oxidative stress: role of mitochondria and
protection by glutathione. Biofactors
8: 7-11,
1998.[ISI][Medline]
- Galan A,
Garcia-Bermejo ML, Troyano A, Vilaboa NE, de Blas E, Kazanietz MG, and Aller
P. Stimulation of p38 mitogen-activated protein kinase is an early
regulatory event for the cadmium-induced apoptosis in human promonocytic
cells. J Biol Chem 275:
11418-11424, 2000.[Abstract/Free Full Text]
- Ghatan S,
Larner S, Kinoshita Y, Hetman M, Patel L, Xia Z, Youle RJ, and Morrison
RS. p38 MAP kinase mediates bax translocation in nitric oxide-induced
apoptosis in neurons. J Cell Biol
150: 335-347,
2000.[Abstract/Free Full Text]
- Goping IS,
Gross A, Lavoie JN, Nguyen M, Jemmerson R, Roth K, Korsmeyer SJ, and Shore
GC. Regulated targeting of BAX to mitochondria. J Cell
Biol 143:
207-215, 1998.[Abstract/Free Full Text]
- Gratton JP,
Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, and Sessa WC. Akt
down-regulation of p38 signaling provides a novel mechanism of vascular
endothelial growth factor-mediated cytoprotection in endothelial cells.
J Biol Chem 276:
30359-30365, 2001.[Abstract/Free Full Text]
- Guo YL, Kang B,
and Williamson JR. Inhibition of the expression of mitogen-activated
protein phosphatase-1 potentiates apoptosis induced by tumor necrosis
factor-
in rat mesangial cells. J Biol Chem
273: 10362-10366,
1998.[Abstract/Free Full Text]
- Hajnoczky G,
Gao E, Nomura T, Hoek JB, and Thomas AP. Multiple mechanisms by which
protein kinase A potentiates inositol 1,4,5-trisphosphate-induced
Ca2+ mobilization in permeabilized hepatocytes.
Biochem J 293:
413-422, 1993.[ISI][Medline]
- Hong F, Kim WH,
Tian Z, Jaruga B, Ishac E, Shen X, and Gao B. Elevated interleukin-6
during ethanol consumption acts as a potential endogenous protective cytokine
against ethanol-induced apoptosis in the liver: involvement of induction of
Bcl-2 and Bcl-x(L) proteins. Oncogene
21: 32-43,
2002.[ISI][Medline]
- Ichijo H,
Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K,
Miyazono K, and Gotoh Y. Induction of apoptosis by ASK1, a mammalian
MAPKKK that activates SAPK/JNK and p38 signaling pathways.
Science 275:
90-94, 1997.[Abstract/Free Full Text]
- Iimuro Y,
Gallucci RM, Luster MI, Kono H, and Thurman RG. Antibodies to tumor
necrosis factor-
attenuate hepatic necrosis and inflammation caused by
chronic exposure to ethanol in the rat. Hepatology
26: 1530-1537,
1997.[ISI][Medline]
- Kang YJ, Zhou
ZX, Wang GW, Buridi A, and Klein JB. Suppression by metallothionein of
doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38
mitogen-activated protein kinases. J Biol Chem
275: 13690-13698,
2000.[Abstract/Free Full Text]
- Kataoka T,
Schroter M, Hahne M, Schneider P, Irmler M, Thome M, Froelich CJ, and Tschopp
J. FLIP prevents apoptosis induced by death receptors but not by
perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation.
J Immunol 161:
3936-3942, 1998.[Abstract/Free Full Text]
- Khoruts A,
Stahnke L, McClain CJ, Logan G, and Allen JI. Circulating tumor necrosis
factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic
patients. Hepatology 13:
267-276, 1991.[ISI][Medline]
- Kimura N,
Matsuo R, Shibuya H, Nakashima K, and Taga T. BMP2-induced apoptosis is
mediated by activation of the TAK1-p38 kinase pathway that is negatively
regulated by Smad6. J Biol Chem
275: 17647-17652,
2000.[Abstract/Free Full Text]
- Korsmeyer SJ. BCL-2 gene family and the regulation of
programmed cell death. Cancer Res
59, Suppl 7:
1693s-1700s, 1999.[ISI][Medline]
- Li H, Zhu H, Xu
CJ, and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial
damage in the Fas pathway of apoptosis. Cell
94: 491-501,
1998.[ISI][Medline]
- Lieber CS and
DeCarli LM. The feeding of alcohol in liquid diets: two decades of
applications and 1982 update. Alcohol Clin Exp Res
6: 523-531,
1982.[ISI][Medline]
- Luo X,
Budihardjo I, Zou H, Slaughter C, and Wang X. Bid, a Bcl2 interacting
protein, mediates cytochrome c release from mitochondria in response
to activation of cell surface death receptors. Cell
94: 481-490,
1998.[ISI][Medline]
- Mackay K and
Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein kinase
protects neonatal cardiac myocytes from ischemia. J Biol
Chem 274:
6272-6279, 1999.[Abstract/Free Full Text]
- Mackay K and
Mochly-Rosen D. Involvement of a p38 mitogen-activated protein kinase
phosphatase in protecting neonatal rat cardiac myocytes from ischemia.
J Mol Cell Cardiol 32:
1585-1588, 2000.[ISI][Medline]
- Madesh M,
Antonsson B, Srinivasula SM, Alnemri ES, and Hajnoczky G. Rapid kinetics
of tBid-induced cytochrome c and Smac/DIABLO release and
mitochondrial depolarization. J Biol Chem
277: 5651-5659,
2002.[Abstract/Free Full Text]
- McClain C, Hill
D, Schmidt J, and Diehl AM. Cytokines and alcoholic liver disease.
Semin Liver Dis 13:
170-182, 1993.[ISI][Medline]
- McClain CJ and
Cohen DA. Increased tumor necrosis factor production by monocytes in
alcoholic hepatitis. Hepatology
9: 349-351,
1989.[ISI][Medline]
- Murphy KM,
Streips UN, and Lock RB. Bax membrane insertion during Fas (CD95)-induced
apoptosis precedes cytochrome c release and is inhibited by Bcl-2.
Oncogene 18:
5991-5999, 1999.[ISI][Medline]
- Nechushtan A,
Smith CL, Hsu YT, and Youle RJ. Conformation of the Bax C-terminus
regulates subcellular location and cell death. EMBO J
18: 2330-2341,
1999.[Abstract/Free Full Text]
- Pastorino JG and Hoek JB. Ethanol potentiates tumor necrosis factor-
cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting
induction of the mitochondrial permeability transition.
Hepatology 31:
1141-1152, 2000.[ISI][Medline]
- Pastorino JG,
Marcineviciute A, Cahill A, and Hoek JB. Potentiation by chronic ethanol
treatment of the mitochondrial permeability transition. Biochem
Biophys Res Commun 265:
405-409, 1999.[ISI][Medline]
- Pastorino JG,
Tafani M, and Farber JL. Tumor necrosis factor induces phosphorylation and
translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent
pathway. J Biol Chem 274:
19411-19416, 1999.[Abstract/Free Full Text]
- Perez D and
White E. TNF-
signals apoptosis through a bid-dependent
conformational change in Bax that is inhibited by E1B 19K. Mol
Cell 6: 53-63,
2000.[ISI][Medline]
- Priault M,
Camougrand N, Chaudhuri B, and Manon S. Role of the C-terminal domain of
Bax and Bcl-XL in their localization and function in yeast cells.
FEBS Lett 443:
225-228, 1999.[ISI][Medline]
- Saitoh M,
Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K,
and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis
signalregulating kinase (ASK) 1. EMBO J
17: 2596-2606,
1998.[Abstract/Free Full Text]
- Salvesen GS and
Dixit VM. Caspase activation: the induced-proximity model. Proc
Natl Acad Sci USA 96:
10964-10967, 1999.[Abstract/Free Full Text]
- Scaffidi C,
Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH,
and Peter ME. Two CD95 (APO-1/Fas) signaling pathways. EMBO
J 17: 1675-1687,
1998.[Abstract/Free Full Text]
- Scaffidi C,
Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, and Peter ME. Differential
modulation of apoptosis sensitivity in CD95 type I and type II cells.
J Biol Chem 274:
22532-22538, 1999.[Abstract/Free Full Text]
- Slee EA, Harte
MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson
DW, Alnemri ES, Green DR, and Martin SJ. Ordering the cytochrome
c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6,
-7, -8, and -10 in a caspase-9-dependent manner. J Cell
Biol 144:
281-292, 1999.[Abstract/Free Full Text]
- Susin SA,
Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, Fassy F, Reed JC, and
Kroemer G. The central executioner of apoptosis: multiple connections
between protease activation and mitochondria in Fas/APO-1/CD95- and
ceramide-induced apoptosis. J Exp Med
186: 25-37,
1997.[Abstract/Free Full Text]
- Torcia M, De
Chiara G, Nencioni L, Ammendola S, Labardi D, Lucibello M, Rosini P, Marlier
LN, Bonini P, Dello Sbarba P, Palamara AT, Zambrano N, Russo T, Garaci E, and
Cozzolino F. Nerve growth factor inhibits apoptosis in memory B
lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation,
and cytochrome c release. J Biol Chem
276: 39027-39036,
2001.[Abstract/Free Full Text]
- Tremblais K,
Oliver L, Juin P, Le Cabellec TM, Meflah K, and Vallette FM. The
C-terminus of bax is not a membrane addressing/anchoring signal.
Biochem Biophys Res Commun 260:
582-591, 1999.[ISI][Medline]
- Tsuruta F,
Masuyama N, and Gotoh Y. The phosphatidylinositol 3-kinase (PI3K)-Akt
pathway suppresses Bax translocation to mitochondria. J Biol
Chem 277:
14040-14047, 2002.[Abstract/Free Full Text]
- Wajant H,
Johannes FJ, Haas E, Siemienski K, Schwenzer R, Schubert G, Weiss T, Grell M,
and Scheurich P. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and
TRAIL-R/Apo2-mediated cell death but not gene induction. Curr
Biol 8: 113-116,
1998.[ISI][Medline]
- Wang HG, Pathan
N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke
TF, and Reed JC. Ca2+-induced apoptosis through
calcineurin dephosphorylation of BAD. Science
284: 339-343,
1999.[Abstract/Free Full Text]
- Wang J, Lobito
AA, Shen F, Hornung F, Winoto A, and Lenardo MJ. Inhibition of
Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP.
Eur J Immunol 30:
155-163, 2000.[ISI][Medline]
- Wu D and
Cederbaum AI. Ethanol-induced apoptosis to stable HepG2 cell lines
expressing human cytochrome P-4502E1. Alcohol Clin Exp
Res 23: 67-76,
1999.[ISI][Medline]
- Wu D and
Cederbaum AI. Removal of glutathione produces apoptosis and necrosis in
HepG2 cells overexpressing CYP2E1. Alcohol Clin Exp
Res 25: 619-628,
2001.[ISI][Medline]
- Yoshino T,
Kishi H, Nagata T, Tsukada K, Saito S, and Muraguchi A. Differential
involvement of p38 MAP kinase pathway and Bax translocation in the
mitochondria-mediated cell death in TCR- and dexamethasone-stimulated
thymocytes. Eur J Immunol 31:
2702-2708, 2001.[ISI][Medline]
- Zhang FX, Rubin
R, and Rooney TA. N-methyl-D-aspartate inhibits
apoptosis through activation of phosphatidylinositol 3-kinase in cerebellar
granule neurons. A role for insulin receptor substrate-1 in the neurotrophic
action of N-methyl-D-aspartate and its inhibition by
ethanol. J Biol Chem 273:
26596-26602, 1998.[Abstract/Free Full Text]
- Zhuang S,
Demirs JT, and Kochevar IE. p38 mitogen-activated protein kinase mediates
bid cleavage, mitochondrial dysfunction, and caspase-3 activation during
apoptosis induced by singlet oxygen but not by hydrogen peroxide. J
Biol Chem 275:
25939-25948, 2000.[Abstract/Free Full Text]